Brief: Journey Medical Corporation Announces Positive Comparative Pharmacokinetic Data For Dfd-29

Journey Medical

20/12/2022 13:34

Dec 20 (Reuters) - Journey Medical Corp  DERM.O :
    * JOURNEY MEDICAL CORPORATION ANNOUNCES POSITIVE COMPARATIVE
PHARMACOKINETIC (PK) DATA FOR DFD-29
    * FURTHER UPDATES ON DFD-29 PROGRAM INCLUDING POTENTIAL
TOPLINE
DATA FROM PHASE 3 STUDIES, ANTICIPATED IN FIRST HALF OF 2023
    * PLANS TO FILE A NEW DRUG APPLICATION ("NDA") IN SECOND
HALF OF
2023
    * PK STUDY FOR DFD-29 SHOWED THAT FOOD DID NOT HAVE A
SIGNIFICANT
EFFECT ON PHARMACOKINETICS OF DFD-29

Source text for Eikon:  ID:nGNX4tJ87K 
Further company coverage:  DERM.O 
 ((Reuters.Briefs@thomsonreuters.com))